Products for Research Use Only
RegisterLogin

SARS-CoV-2-IN-35

CAT: 0804-HY-148387Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-148387Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1].
CAS Number
2757763-47-4
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-35.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC2=CC=CC=C2S1)[C@H](C[C@H]3C(NCC3)=O)NC([C@@H]4[C@]5([H])[C@@](CN4C([C@H](C(C)C)NC(C(F)(F)F)=O)=O)([H])C5(C)C)=O
Molecular Formula
C29H34F3N5O5S
Molecular Weight
621.67
References & Citations
[1]Owen DR, et, al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021 Dec 24;374 (6575) :1586-1593.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-170545SARS-CoV-2 Mpro-IN-35
HY-135856-01SARS-CoV-IN-2
HY-156337SARS-CoV-2-IN-63
HY-143417SARS-CoV-2-IN-16
HY-162777SARS-CoV-2-IN-93
HY-162414SARS-CoV-2-IN-84
HY-168107SARS-CoV-2-IN-98
HY-162604SARS-CoV-2-IN-90
HY-155308SARS-CoV-2-IN-61
HY-169419SARS-CoV-2-IN-108

Alternative Products

CatalogName
T204535-01SARS-CoV-2 Mpro-IN-35
CRB1001792-01SARS-CoV-2 NSP7 (21-35)
GTR18678023-01SARS-CoV/SARS-CoV-2 Spike Antibody
CRB1001792-01SARS-CoV-2 NSP7 (21-35) - (Antimicrobial Peptides - AMP)
AS179347-01SARS-CoV-IN-2
553226SARS-CoV-2
Oneq-S827-150RSARS CoV-2
C21524-50uLSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody [E8H21]
E2S209908SARS CoV/SARS CoV 2 Spike Human mAb

Popular Products